NCT07180212 2026-03-17
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
Tianjin Medical University Second Hospital
Phase NA Recruiting
Clinical Trials
10 trialsNCT07000084 2026-03-04
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06704191 2025-09-22
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Mayo Clinic
Phase 1/2 Recruiting
NCT05438563 2025-09-09
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT06944314 2025-04-27
Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia
Marmara University
Phase NA Enrolling by invitation
NCT02901548 2022-07-29
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT05362539 2022-05-05
Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria
Mansoura University
Phase NA Completed
NCT03831321 2019-02-05
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Istanbul Medeniyet University
Phase 4 Unknown
NCT02145390 2018-08-28
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
University of Miami
Phase NA Terminated
NCT00556621 2015-07-30
GEMCIRAV
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed